维尔生物技术 VIR
$12.21 +$1.19 (+10.80%)
休市 · Nov 7, 5:10 am ET · 最新盘后价 $12.32 +0.91%
开盘$11.30
昨收$11.02
当日区间$11.30 – $12.45
成交量1.90M
市值$2.09B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$238.94M+23,075.1% YoY
营业利润$73.47M+162.0% YoY
净利润$80.08M+172.2% YoY
摊薄每股收益$0.47+158.8% YoY
自由现金流$123.29M+200.4% YoY
经营现金流$123.33M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率100.0%
营业利润率-92.6%
净利率-83.2%
净资产收益率-26.1%
资产收益率-20.9%
投入资本回报率-25.6%
流动比率6.04
负债/资产比率19.1%
现金及投资$532.73M
总负债$84.14M
净现金（净负债）$448.59M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $238.95M | -$29,000.00 | $68.56M | $64.07M | $240,000.00 |
| 营业总收入 | $238.94M | -$41,000.00 | $66.52M | $63.76M | -$65,000.00 |
| 营业成本 | $0.00 | – | $26,000.00 | $26,000.00 | -$11,000.00 |
| 毛利润 | $238.94M | – | $66.49M | $63.73M | -$54,000.00 |
| 营业费用 | $165.47M | $132.25M | $546.00M | $111.66M | $173.39M |
| 销售及管理费用 | $30.20M | $23.34M | $92.07M | $23.62M | $22.23M |
| 研发费用 | $135.28M | $108.92M | $455.97M | $88.35M | $151.46M |
| 其他营业费用 | -$11,000.00 | -$12,000.00 | -$2.04M | -$310,000.00 | -$305,000.00 |
| 营业利润 | $73.47M | -$132.29M | -$479.51M | -$47.92M | -$173.44M |
| 非经营性利息净收入（支出） | $8.97M | $7.19M | $40.24M | $7.80M | $9.36M |
| 非经营性利息收入 | $8.97M | $7.19M | $40.24M | $7.80M | $9.36M |
| 其他收入（支出） | -$2.17M | -$424,000.00 | $1.50M | -$2.94M | $1.11M |
| 证券出售收益 | -$1.72M | -$170,000.00 | $1.73M | -$2.61M | $1.34M |
| 特殊收益（费用） | $0.00 | $0.00 | $182,000.00 | $0.00 | $0.00 |
| -减：重组及并购费用 | $0.00 | $0.00 | -$182,000.00 | $0.00 | $0.00 |
| 其他非经营性收入（支出） | -$451,000.00 | -$254,000.00 | -$409,000.00 | -$335,000.00 | -$228,000.00 |
| 税前利润 | $80.26M | -$125.53M | -$437.77M | -$43.06M | -$162.97M |
| 税费 | $179,000.00 | $170,000.00 | $217,000.00 | -$137,000.00 | $168,000.00 |
| 净利润 | $80.08M | -$125.70M | -$437.99M | -$42.92M | -$163.14M |
| 持续经营利润 | $80.08M | -$125.70M | -$437.99M | -$42.92M | -$163.14M |
| 归属母公司净利润 | $80.08M | -$125.70M | -$437.99M | -$42.92M | -$163.14M |
| 归属普通股股东净利润 | $80.08M | -$125.70M | -$437.99M | -$42.92M | -$163.14M |
| 基本每股收益 | $0.48 | -$0.85 | -$3.16 | -$0.31 | -$1.17 |
| 摊薄每股收益 | $0.47 | -$0.85 | -$3.16 | -$0.31 | -$1.17 |
| 少数股东权益 | – | – | $0.00 | – | – |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $1.21B | $1.03B | $1.00B | $1.00B | $1.02B |
| 流动资产合计 | $573.74M | $522.99M | $514.08M | $514.08M | $545.68M |
| 现金及现金等价物与短期投资 | $532.73M | $476.30M | $467.02M | $467.02M | $506.51M |
| -现金及现金等价物 | $278.73M | $274.16M | $232.19M | $232.19M | $170.08M |
| -短期投资 | $254.00M | $202.14M | $234.83M | $234.83M | $336.43M |
| 受限现金 | $1.93M | $1.93M | $1.92M | $1.92M | $2.22M |
| 其他流动资产 | $39.08M | $44.76M | $45.14M | $45.14M | $36.96M |
| 非流动资产合计 | $641.07M | $502.60M | $488.74M | $488.74M | $473.77M |
| 固定资产净值 | $109.82M | $113.92M | $117.72M | $117.72M | $121.76M |
| -固定资产原值 | $162.45M | $163.82M | $164.88M | $164.88M | $166.25M |
| -累计折旧 | -$52.63M | -$49.90M | -$47.16M | -$47.16M | -$44.49M |
| 投资及预付款 | $475.02M | $332.97M | $314.58M | $314.58M | $304.21M |
| -可供出售证券 | $475.02M | $332.97M | $314.58M | $314.58M | $304.21M |
| 商誉及其他无形资产 | $24.64M | $24.71M | $24.79M | $24.79M | $24.86M |
| -商誉 | $16.94M | $16.94M | $16.94M | $16.94M | $16.94M |
| -其他无形资产 | $7.70M | $7.78M | $7.85M | $7.85M | $7.92M |
| 其他非流动资产 | $31.59M | $31.00M | $31.66M | $31.66M | $22.94M |
| 负债合计 | $232.31M | $212.82M | $237.55M | $237.55M | $223.36M |
| 流动负债合计 | $94.96M | $73.56M | $92.82M | $92.82M | $75.22M |
| 应付款 | $19.59M | $7.27M | $11.63M | $11.63M | $8.97M |
| -应付账款 | $17.75M | $5.45M | $9.80M | $9.80M | $6.85M |
| -其他应付款 | $1.83M | $1.83M | $1.83M | $1.83M | $2.12M |
| 一年内应计费用 | $66.24M | $57.34M | $72.39M | $72.39M | $57.30M |
| 短期债务及融资租赁负债 | $9.14M | $8.94M | $8.80M | $8.80M | $8.96M |
| -一年内到期融资租赁负债 | $9.14M | $8.94M | $8.80M | $8.80M | $8.96M |
| 非流动负债合计 | $137.35M | $139.26M | $144.73M | $144.73M | $148.13M |
| 长期债务及融资租赁负债 | $84.14M | $86.64M | $89.05M | $89.05M | $91.22M |
| -长期融资租赁负债 | $84.14M | $86.64M | $89.05M | $89.05M | $91.22M |
| 其他非流动负债 | $53.22M | $52.63M | $55.68M | $55.68M | $47.49M |
| 股东权益合计 | $982.49M | $812.77M | $765.28M | $765.28M | $796.10M |
| 股东权益 | $982.49M | $812.77M | $765.28M | $765.28M | $796.10M |
| 股本 | $17,000.00 | $16,000.00 | $14,000.00 | $14,000.00 | $14,000.00 |
| -普通股 | $17,000.00 | $16,000.00 | $14,000.00 | $14,000.00 | $14,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $2.23B | $2.14B | $1.97B | $1.97B | $1.95B |
| 留存收益 | -$1.24B | -$1.32B | -$1.20B | -$1.20B | -$1.15B |
| 不影响留存收益的损益 | -$4.60M | -$3.48M | -$2.06M | -$2.06M | -$1.91M |
| 一年内递延负债 | – | – | $0.00 | $0.00 | $0.00 |
| 一年以上递延负债 | – | – | – | – | $9.43M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | $123.33M | -$132.39M | -$391.78M | -$25.88M | -$167.57M |
| 持续经营经营活动现金流净额 | $123.33M | -$132.39M | -$391.78M | -$25.88M | -$167.57M |
| 持续经营净利润 | $80.08M | -$125.70M | -$437.99M | -$42.92M | -$163.14M |
| 折旧、折耗与摊销 | $2.80M | $2.81M | $11.68M | $2.90M | $3.00M |
| 其他非现金项目 | $2.42M | $530,000.00 | $156,000.00 | -$5.85M | $9.78M |
| 营运资金变动 | $23.47M | -$22.68M | -$22.45M | -$2.84M | -$20.60M |
| -预付资产变动 | $5.68M | $382,000.00 | $2.08M | -$8.08M | $4.22M |
| -应付账款及应计费用变动 | $20.70M | -$21.45M | -$4.51M | $13.06M | -$17.02M |
| -其他流动资产变动 | -$604,000.00 | $657,000.00 | -$12.64M | -$8.72M | -$2.79M |
| -其他流动负债变动 | -$2.31M | -$2.27M | -$7.37M | -$2.32M | -$1.79M |
| 投资活动现金流净额 | -$197.14M | $11.84M | $310.37M | $86.65M | $40.45M |
| 持续经营投资活动现金流净额 | -$197.14M | $11.84M | $310.37M | $86.65M | $40.45M |
| 固定资产购置及出售净额 | -$32,000.00 | -$390,000.00 | -$4.58M | -$458,000.00 | -$280,000.00 |
| 投资购置及出售净额 | -$197.11M | $12.23M | $314.95M | $87.11M | $40.73M |
| 筹资活动现金流 | $78.38M | $162.52M | $3.79M | $1.04M | $102,000.00 |
| 持续经营筹资活动现金流净额 | $78.38M | $162.52M | $3.79M | $1.04M | $102,000.00 |
| 普通股发行净额 | $75.58M | $162.35M | – | – | – |
| 股票期权行使所得 | $2.80M | $174,000.00 | $4.15M | $1.04M | $101,000.00 |
| 期末现金余额 | $287.60M | $283.04M | $241.07M | $241.07M | $179.26M |
| 现金净变动 | $4.56M | $41.97M | -$77.63M | $61.81M | -$127.02M |
| 期初现金余额 | $283.04M | $241.07M | $318.70M | $179.26M | $306.28M |
| 自由现金流 | $123.29M | -$132.78M | -$396.61M | -$26.22M | -$167.89M |
| 其他筹资费用净额 | – | – | -$361,000.00 | -$2,000.00 | $1,000.00 |
| 递延税款 | – | – | – | – | -$19,000.00 |
暂无评论——快来第一个聊聊 VIR。